TY - JOUR
T1 - Dissecting the polygenic basis of atherosclerosis via disease-associated cell state signatures
AU - Örd, Tiit
AU - Lönnberg, Tapio
AU - Nurminen, Valtteri
AU - Ravindran, Aarthi
AU - Niskanen, Henri
AU - Kiema, Miika
AU - Õunap, Kadri
AU - Maria, Maleeha
AU - Moreau, Pierre R.
AU - Mishra, Pashupati P.
AU - Palani, Senthil
AU - Virta, Jenni
AU - Liljenbäck, Heidi
AU - Aavik, Einari
AU - Roivainen, Anne
AU - Ylä-Herttuala, Seppo
AU - Laakkonen, Johanna P.
AU - Lehtimäki, Terho
AU - Kaikkonen, Minna U.
N1 - Publisher Copyright:
© 2023 The Author(s)
PY - 2023/5/4
Y1 - 2023/5/4
N2 - Coronary artery disease (CAD) is a pandemic disease where up to half of the risk is explained by genetic factors. Advanced insights into the genetic basis of CAD require deeper understanding of the contributions of different cell types, molecular pathways, and genes to disease heritability. Here, we investigate the biological diversity of atherosclerosis-associated cell states and interrogate their contribution to the genetic risk of CAD by using single-cell and bulk RNA sequencing (RNA-seq) of mouse and human lesions. We identified 12 disease-associated cell states that we characterized further by gene set functional profiling, ligand-receptor prediction, and transcription factor inference. Importantly, Vcam1+ smooth muscle cell state genes contributed most to SNP-based heritability of CAD. In line with this, genetic variants near smooth muscle cell state genes and regulatory elements explained the largest fraction of CAD-risk variance between individuals. Using this information for variant prioritization, we derived a hybrid polygenic risk score (PRS) that demonstrated improved performance over a classical PRS. Our results provide insights into the biological mechanisms associated with CAD risk, which could make a promising contribution to precision medicine and tailored therapeutic interventions in the future.
AB - Coronary artery disease (CAD) is a pandemic disease where up to half of the risk is explained by genetic factors. Advanced insights into the genetic basis of CAD require deeper understanding of the contributions of different cell types, molecular pathways, and genes to disease heritability. Here, we investigate the biological diversity of atherosclerosis-associated cell states and interrogate their contribution to the genetic risk of CAD by using single-cell and bulk RNA sequencing (RNA-seq) of mouse and human lesions. We identified 12 disease-associated cell states that we characterized further by gene set functional profiling, ligand-receptor prediction, and transcription factor inference. Importantly, Vcam1+ smooth muscle cell state genes contributed most to SNP-based heritability of CAD. In line with this, genetic variants near smooth muscle cell state genes and regulatory elements explained the largest fraction of CAD-risk variance between individuals. Using this information for variant prioritization, we derived a hybrid polygenic risk score (PRS) that demonstrated improved performance over a classical PRS. Our results provide insights into the biological mechanisms associated with CAD risk, which could make a promising contribution to precision medicine and tailored therapeutic interventions in the future.
KW - atherosclerosis
KW - cell state
KW - coronary artery disease
KW - genetics
KW - genome-wide association study
KW - GWAS
KW - polygenic risk score
KW - scRNA-seq
KW - single cell
UR - http://www.scopus.com/inward/record.url?scp=85153608064&partnerID=8YFLogxK
U2 - 10.1016/j.ajhg.2023.03.013
DO - 10.1016/j.ajhg.2023.03.013
M3 - Article
C2 - 37060905
AN - SCOPUS:85153608064
SN - 0002-9297
VL - 110
SP - 722
EP - 740
JO - American Journal of Human Genetics
JF - American Journal of Human Genetics
IS - 5
ER -